Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Baxter
Citi
McKinsey
Cipla
US Army
Federal Trade Commission
Chubb

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091471

« Back to Dashboard

NDA 091471 describes EFAVIRENZ, which is a drug marketed by Aurobindo Pharma Ltd, Mylan Pharms Inc, and Strides Pharma, and is included in three NDAs. It is available from five suppliers. Additional details are available on the EFAVIRENZ profile page.

The generic ingredient in EFAVIRENZ is efavirenz. There are twenty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the efavirenz profile page.
Summary for 091471
Tradename:EFAVIRENZ
Applicant:Mylan Pharms Inc
Ingredient:efavirenz
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 091471
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EFAVIRENZ efavirenz TABLET;ORAL 091471 ANDA Mylan Pharmaceuticals Inc. 0378-2233 N 0378-2233-93
EFAVIRENZ efavirenz TABLET;ORAL 091471 ANDA REMEDYREPACK INC. 70518-1013 N 70518-1013-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Feb 17, 2016TE:ABRLD:No
Regulatory Exclusivity Expiration:Feb 14, 2018
Regulatory Exclusivity Use:PATENT CHALLENGE

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fuji
Dow
Queensland Health
Fish and Richardson
Covington
Deloitte
Medtronic
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.